Sonoma Pharmaceuticals conducts business under Healthcare sector and is part of Drug Manufacturers?Specialty & Generic industry. On a scale of 0 to 100, Sonoma Pharmaceuticals holds a performance score of 5. The entity has a beta of -0.075, which indicates not very significant fluctuations relative to the market. Let's try to break down what Sonoma's beta means in this case. As returns on the market increase, returns on owning Sonoma Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Sonoma Pharmaceuticals is likely to outperform the market. Although it is vital to follow Sonoma Pharmaceuticals current price movements, it is good to be conservative about what you can do with the information regarding equity historical returns. The philosophy towards measuring future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By inspecting Sonoma Pharmaceuticals technical indicators, you can presently evaluate if the expected return of 0.47% will be sustainable into the future. Please operates Sonoma Pharmaceuticals variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and semi variance to make a quick decision on whether Sonoma Pharmaceuticals existing price patterns will revert.